Papademetriou V, Burris J, Kukich S, Freis E D
Arch Intern Med. 1985 Nov;145(11):1986-90.
Potassium chloride was compared with triamterene in a crossover trial involving 16 hypertensive patients with overt diuretic-induced hypokalemia. Potassium chloride, 24 to 96 mEq/day, normalized the plasma potassium (PK) level at 3.5 mEq/L or more in only eight of the patients. The average increase in PK level was 0.58 mEq/L. Triamterene, 50 to 200 mg daily, normalized PK level in ten of the patients. The average increase in PK level was 0.72 mEq/L, which was not significantly different than that with potassium therapy. Some patients who responded to potassium did not respond to triamterene, and vice versa. Most of the administered potassium was excreted in the urine even with persisting hypokalemia. Addition of triamterene to diuretic therapy resulted in a small but statistically significant increase in plasma creatinine level.
在一项交叉试验中,对16例因使用利尿剂导致明显低钾血症的高血压患者,将氯化钾与氨苯蝶啶进行了比较。每天24至96毫当量的氯化钾仅使8例患者的血浆钾(PK)水平恢复正常(达到3.5毫当量/升或更高)。PK水平的平均升高为0.58毫当量/升。每天50至200毫克的氨苯蝶啶使10例患者的PK水平恢复正常。PK水平的平均升高为0.72毫当量/升,与钾治疗相比无显著差异。一些对钾有反应的患者对氨苯蝶啶无反应,反之亦然。即使存在持续低钾血症,大部分摄入的钾仍通过尿液排出。在利尿剂治疗中加用氨苯蝶啶会使血浆肌酐水平有小幅但具有统计学意义的升高。